Literature DB >> 14978760

Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins.

Marshall S Horwitz1.   

Abstract

This manuscript will contain a brief review of adenovirus (Ad) biology including its structure and the spectrum of clinical diseases that it causes. Newer findings about the interactions of Ad early region 3 (E3) proteins with host proteins and signal transduction processes, which control the inflammatory response, will be described. Some of these processes affect the strategies for using Ads as vectors for gene therapy. There are many excellent reviews of some of these aspects 1. The history of the discoveries that led to the use of Ads as vectors as well as key experiments that resulted in improvements to various aspects of these systems have also been reviewed recently 2. The use of Ad E3 immunoregulatory genes to facilitate allogeneic transplantation and prevent autoimmune diabetes will be described. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978760     DOI: 10.1002/jgm.495

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  50 in total

1.  Expression of optineurin isolated from rat-injured dental pulp and the effects on inflammatory signals in normal rat kidney cells.

Authors:  Kyoko Senoo; Keisuke Yamashiro; Tadashi Yamamoto; Fumio Myokai; Mari Kawamura; Shogo Takashiba
Journal:  Odontology       Date:  2017-08-03       Impact factor: 2.634

2.  Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

4.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Authors:  Hideyo Ugai; Anton V Borovjagin; Long P Le; Minghui Wang; David T Curiel
Journal:  J Mol Biol       Date:  2006-12-06       Impact factor: 5.469

6.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

7.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Host range, prevalence, and genetic diversity of adenoviruses in bats.

Authors:  Yan Li; Xingyi Ge; Huajun Zhang; Peng Zhou; Yan Zhu; Yunzhi Zhang; Junfa Yuan; Lin-Fa Wang; Zhengli Shi
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Adenovirus RID-alpha activates an autonomous cholesterol regulatory mechanism that rescues defects linked to Niemann-Pick disease type C.

Authors:  Nicholas L Cianciola; Cathleen R Carlin
Journal:  J Cell Biol       Date:  2009-11-16       Impact factor: 10.539

10.  Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates.

Authors:  Soeren Hofmayer; Ijad Madisch; Sebastian Darr; Fabienne Rehren; Albert Heim
Journal:  BMC Genomics       Date:  2009-11-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.